BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11719844)

  • 1. Comment to: F. M. Nackhoul et al. (2001) Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44: 602-604.
    Schaer DJ
    Diabetologia; 2001 Nov; 44(11):2104-5. PubMed ID: 11719844
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment to: F. M. Nakhoul et al. (2001) Haptoglobin phenotype and diabetes. Diabetologia 44: 602-604.
    Moczulski DK; Rogus JJ; Krolewski AS
    Diabetologia; 2001 Dec; 44(12):2237-8. PubMed ID: 11793027
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypothesis--haptoglobin genotype and diabetic nephropathy.
    Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
    Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haptoglobin groups and serum cholesterol levels.
    Fröhlander N
    Hum Hered; 1987; 37(5):323-5. PubMed ID: 3666763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel DNA polymorphism (4886C>T) in the human LCAT gene.
    Recalde D; Cenarro A; Civeira F; Garcia-Otin AL; Pocovi M
    Hum Mutat; 2000 Mar; 15(3):298. PubMed ID: 10679956
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of a xylosyltransferase II gene haplotype marker for diabetic nephropathy in type 1 diabetes.
    Hendig D; Tarnow L; Kuhn J; Kleesiek K; Götting C
    Clin Chim Acta; 2008 Dec; 398(1-2):90-4. PubMed ID: 18789912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients.
    Koda Y; Soejima M; Yamagishi S; Amano S; Okamoto T; Inagaki Y; Yamada K; Kimura H
    Diabetologia; 2002 Jul; 45(7):1039-40. PubMed ID: 12187922
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on: Lin et al. (2007) SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes: Diabetes 56: 1177-1180.
    Rudofsky G; Schlotterer A; Nawroth PP; Bierhaus A; Hamann A
    Diabetes; 2007 Aug; 56(8):e11; author reply e12-3. PubMed ID: 17660269
    [No Abstract]   [Full Text] [Related]  

  • 10. Human haptoglobin structure and function--a molecular modelling study.
    Polticelli F; Bocedi A; Minervini G; Ascenzi P
    FEBS J; 2008 Nov; 275(22):5648-56. PubMed ID: 18959750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haptoglobin phenotypes in cervical cancer: decreased risk for Hp2-2 individuals.
    Quaye IK; Agbolosu K; Ibrahim M; Bannerman-Williams P
    Clin Chim Acta; 2009 May; 403(1-2):267-8. PubMed ID: 19296903
    [No Abstract]   [Full Text] [Related]  

  • 12. The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes.
    Schön S; Prante C; Bahr C; Tarnow L; Kuhn J; Kleesiek K; Götting C
    Diabetes Care; 2006 Oct; 29(10):2295-9. PubMed ID: 17003309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new haptoglobin variant found in the Ahirs of Cutch (Gujarat).
    Naik SN; Goshar DT; Ishwad CS
    Indian J Med Res; 1984 Dec; 80():690-2. PubMed ID: 6532972
    [No Abstract]   [Full Text] [Related]  

  • 14. Genes for diabetic nephropathy: sweet prospects on the horizon.
    Karnib HH; Chua S; Gharavi AG
    Kidney Int; 2007 Jan; 71(2):94-6. PubMed ID: 17213854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice.
    Shike T; Gohda T; Tanimoto M; Kobayashi M; Makita Y; Funabiki K; Horikoshi S; Hirose S; Shirai T; Tomino Y
    Nephrol Dial Transplant; 2005 May; 20(5):879-85. PubMed ID: 15769825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin from psoriatic patients exhibits decreased activity in binding haemoglobin and inhibiting lecithin-cholesterol acyltransferase activity.
    Cigliano L; Maresca B; Salvatore A; Nino M; Monfrecola G; Ayala F; Carlucci A; Pugliese RC; Pedone C; Abrescia P
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):417-25. PubMed ID: 18363910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotypic variability in the content of the serum protein haptoglobin in exposure of the body to exogenous and endogenous factors].
    Rafikov KhS; Belova IIu; Emel'ianova AP
    Gig Tr Prof Zabol; 1985 Jan; (1):21-4. PubMed ID: 3972260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Haptoglobin polymorphism in patients with inflammatory bowel diseases].
    Papp M; Lakatos PL; ; Palatka K; Földi I; Udvardy M; Hársfalvi J; Tornai I; Vitális Z; Dinya T; Kovács A; Molnár T; Demeter P; Papp J; Lakatos L; Altorjay I
    Orv Hetil; 2006 Sep; 147(36):1745-50. PubMed ID: 17087019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic variants of haptoglobin in patients with nephrotuberculosis].
    Ubaĭdullaev AM; Kazakov KS; Khakimov MA
    Probl Tuberk; 2002; (7):42-3. PubMed ID: 12561643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of diabetic nephropathy: lessons from mice.
    Breyer MD; Tchekneva E; Qi Z; Takahashi T; Fogo AB; Zhao HJ; Harris RC
    Semin Nephrol; 2007 Mar; 27(2):237-47. PubMed ID: 17418691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.